Investors need to pay close attention to Doximity (DOCS) stock based on the movements in the options market lately.
Doximity (NYSE: DOCS) operates a networking platform for doctors that claims to have 80% of U.S. physicians on it. It's an impressive statistic, but that hasn't been enough of a reason for investors continue buying up the stock this year. While other growth stocks have been thriving due to artificial intelligence (AI), there's not the same level of excitement around Doximity -- even though the company has launched its own chatbot, DocsGPT.
On that note, let's consider one stock whose prospects through the next 10 years look attractive: Doximity (NYSE: DOCS). Doximity runs a platform that allows physicians and others in the medical field to network, look for new job opportunities, catch up on the latest research, call patients for telemedicine visits, and much more. The company makes money primarily by charging subscription fees to pharmaceutical companies and hospitals that advertise their products and job opportunities on its platform.